Special Topic: Glioblastoma> Top 20 Journals
Published September 2011
Authors | Institutions | Journals | Nations
Top 20 Journals
It is natural to expect that cancer journals would dominate the listings in this analysis, and that expectation plays out with the presence of journals like Cancer Research, Clinical Cancer Research, the International Journal of Cancer, and Cancer. In addition, since we are dealing with brain tumors, journals like Neuro-Oncology, Neurosurgery, and Acta Neuropathology are also expected. Since glioblastoma research also includes basic science research into molecular mechanisms and genetics, we see journals like the Journal of Biological Chemistry, Molecular Cell Biology, the Journal of Immunology, and the American Journal of Pathology on the lists.
Thirty-six of the 37 unique titles on the journal lists are in the top 50% in their fields in Essential Science IndicatorsSM from Clarivate. Three of these journals rank #1 in their respective categories: the Journal of Biological Chemistry in Biology & Biochemistry, the Journal of Immunology in Immunology, and the New England Journal of Medicine in Clinical Medicine. Seven more journals rank among the top 10 in their fields; a further 10 rank in the top 50; and four others rank in the top 100.
- Citations
- Papers
- Citations Per Paper
- About the Journals
- Overall General Information
- Additional Information
Citations
| Rank | Journal | Citations | Papers | Cites per paper |
|---|---|---|---|---|
| 1 | CANCER RES | 21,267 | 444 | 47.90 |
| 2 | CLIN CANCER RES | 8,792 | 283 | 31.07 |
| 3 | J NEURO-ONCOL | 8,588 | 775 | 11.08 |
| 4 | J CLIN ONCOL | 8,324 | 129 | 64.53 |
| 5 | ONCOGENE | 6,575 | 200 | 32.88 |
| 6 | NEW ENGL J MED | 4,862 | 9 | 540.22 |
| 7 | P NATL ACAD SCI USA | 4,583 | 86 | 53.29 |
| 8 | INT J CANCER | 4,221 | 189 | 22.33 |
| 9 | NEURO-ONCOLOGY | 4,131 | 284 | 14.55 |
| 10 | J BIOL CHEM | 4,068 | 121 | 33.62 |
| 11 | J NEUROSURG | 3,723 | 206 | 18.07 |
| 12 | INT J RADIAT ONCOL | 3,418 | 178 | 19.20 |
| 13 | CANCER CELL | 3,328 | 31 | 107.35 |
| 14 | J NEUROPATH EXP NEUR | 2,800 | 72 | 38.89 |
| 15 | CANCER | 2,366 | 98 | 24.14 |
| 16 | NEUROSURGERY | 2,320 | 131 | 17.71 |
| 17 | ACTA NEUROPATHOL | 2,195 | 94 | 23.35 |
| 18 | NATURE | 2,157 | 9 | 239.67 |
| 19 | MOL CANCER THER | 1,790 | 97 | 18.45 |
| 20 | INT J ONCOL | 1,696 | 149 | 11.38 |
Papers
| Rank | Journal | Citations | Papers | Cites per paper |
|---|---|---|---|---|
| 1 | J NEURO-ONCOL | 8,588 | 775 | 11.08 |
| 2 | CANCER RES | 21,267 | 444 | 47.90 |
| 3 | NEURO-ONCOLOGY | 4,131 | 284 | 14.55 |
| 4 | CLIN CANCER RES | 8,792 | 283 | 31.07 |
| 5 | J NEUROSURG | 3,723 | 206 | 18.07 |
| 6 | ONCOGENE | 6,575 | 200 | 32.88 |
| 7 | INT J CANCER | 4,221 | 189 | 22.33 |
| 8 | INT J RADIAT ONCOL | 3,418 | 178 | 19.20 |
| 9 | ANTICANCER RES | 946 | 149 | 6.35 |
| 10 | INT J ONCOL | 1,696 | 149 | 11.38 |
| 11 | NEUROSURGERY | 2,320 | 131 | 17.71 |
| 12 | J CLIN ONCOL | 8,324 | 129 | 64.53 |
| 13 | J BIOL CHEM | 4,068 | 121 | 33.62 |
| 14 | PLOS ONE | 326 | 105 | 3.10 |
| 15 | CANCER | 2,366 | 98 | 24.14 |
| 16 | MOL CANCER THER | 1,790 | 97 | 18.45 |
| 17 | ONCOL REP | 582 | 96 | 6.06 |
| 18 | BRIT J CANCER | 1,652 | 95 | 17.39 |
| 19 | J CLIN NEUROSCI | 512 | 95 | 5.39 |
| 20 | ACTA NEUROPATHOL | 2,195 | 94 | 23.35 |
Cites Per Paper (>= 16 paper threshold)
| Rank | Journal | Citations | Papers | Cites per paper |
|---|---|---|---|---|
| 1 | CANCER CELL | 3,328 | 31 | 107.35 |
| 2 | J CLIN ONCOL | 8,324 | 129 | 64.53 |
| 3 | J NATL CANCER I | 1,182 | 20 | 59.10 |
| 4 | P NATL ACAD SCI USA | 4,583 | 86 | 53.29 |
| 5 | CANCER RES | 21,267 | 444 | 47.90 |
| 6 | AM J PATHOL | 1,531 | 32 | 47.84 |
| 7 | LAB INVEST | 779 | 19 | 41.00 |
| 8 | J NEUROPATH EXP NEUR | 2,800 | 72 | 38.89 |
| 9 | J BIOL CHEM | 4,068 | 121 | 33.62 |
| 10 | MOL CELL BIOL | 528 | 16 | 33.00 |
| 11 | ONCOGENE | 6,575 | 200 | 32.88 |
| 12 | RADIOLOGY | 846 | 26 | 32.54 |
| 13 | CELL DEATH DIFFER | 542 | 17 | 31.88 |
| 14 | CLIN CANCER RES | 8,792 | 283 | 31.07 |
| 15 | ONCOLOGIST | 483 | 16 | 30.19 |
| 16 | J IMMUNOL | 538 | 18 | 29.89 |
| 17 | J NUCL MED | 1,241 | 42 | 29.55 |
| 18 | ANN ONCOL | 782 | 29 | 26.97 |
| 19 | AM J NEURORADIOL | 1,229 | 48 | 25.60 |
| 20 | NEUROLOGY | 976 | 40 | 24.40 |
About the Journals
The resulting database contained 1,357 journals. Ranked by three separate
measures: citations, papers, and citations per paper. Source dates: January
1, 2001-July 17, 2011. *Unless otherwise specified, all rankings have a
>= 5 paper threshold for all measures.
Look for complelte threshold information for the Special Topic of Glioblastoma in the "Methodology & Threshold" tab of the opening page for this topic.
Overall General Information
Top 20 Scientists, Institutions, Journals, & Nations
Citation tables allow us to map compelling trends:
- Are there particular nations or institutions that might be expected to dominate research in the Topic area, and do the numbers bear out these expectations, or are there surprises?
- Who are the leading scientists and where are they located?
While these tables cannot offer a complete picture, the number of trends and anomalies that can be spotlighted or connected across categories is striking. The tables often lead to renewed perspectives to further explore and validate.
What are Special Topics?
Special Topics, from ScienceWatch.com, is designed to complement Essential Science IndicatorsSM from Clarivate in providing citation analyses and commentary for selected scientific research areas that have experienced notable recent advances or are of special current interest.
Read about the overall methodology for Special Topics in the "What are Special Topics?" page.
Glioblastoma
- Top 20: Authors | Institutions | Journals | Nations
- Papers: 10-Year | 2-Year
- Time Series Graphs
- Field Distribution
- Interviews
SPECIAL TOPICS
- Complete Interview & Topic Menu; all Special Topics with corresponding interviews, essays, or profiles.
- All Topics; date and alphabetically listed.
- Special Topics Home
Image: Gliobastoma WHO grade IV - MRI coronal view, post contrast. 15 year old boy. Wiki Commons.